It depends on how bad the deficiency is and how well the person responds to treatment
Specific POPs have been associated with a higher risk for peripheral neuropathy among those with either impaired fasting glucose or diabetes, beyond the heightened risk due to diabetes itself
Topical glutathione is safe at any concentration for anybody
Rushing this process is the #1 reason people quit
Importantly, because GLP-1 receptor agonists work in a glucose-dependent manner, they generally carry a lower risk of hypoglycaemia compared to some other diabetes medications
In contrast, GLP-1 receptor agonists are particularly effective in reducing major adverse cardiovascular events, while their effect on HF hospitalization appears more modest, with relative risk reductions of approximately 11% (HR 0.89) in pooled analyses [6, 14]